Journal
BIOMARKERS
Volume 14, Issue 7, Pages 529-538Publisher
TAYLOR & FRANCIS LTD
DOI: 10.3109/13547500903150771
Keywords
miRNA; miR-500; hepatocellular carcinoma; liver development; diagnosis
Categories
Funding
- Ministry of Health, Labour, Welfare of Japan
- National Institute of Biomedical Innovation (NiBio)
- Japan Society for the Promotion of Science
Ask authors/readers for more resources
We identified that microRNA expression changed dynamically during liver development and found that miR-500 is an oncofetal miRNA in liver cancer. miR-500 was abundantly expressed in several human liver cancer cell lines and 45% of human hepatocellular carcinoma (HCC) tissue. Most importantly, an increased amount of miR-500 was found in the sera of the HCC patients. In fact, miR-500 levels in sera of the HCC patients returned to normal after the surgical treatment in three HCC patients. Our findings reveal that diverse changes of miRNAs occur during liver development and, one of these, miR-500 is an oncofetal miRNA relevant to the diagnosis of human HCC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available